Transcriptional reprogramming in mantle cell lymphoma promotes BTK inhibitor resistance
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 63 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Mantle cell lymphomaThis series is part of our curated briefing on it.
- Samples
- 63 samples: 52 distinct titles, 7 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Leveraging BRG1 Driven Ferroptosis Resistance to Overcome Treatment ResistancebioRxiv : the preprint server for biology · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE305144_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1304501 and SRA study SRP608124. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 7 samples read as cases, 13 as controls.
How we read this: Read from 63 sample titles: 52 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9162761 MINO parent cells
- GSM9162762 MINO expressing BRG1-T910M mutant
- GSM9162763 MINO expressing wild type BRG1
- GSM9162764 MINO parent cells treated with FHD-286
- GSM9162765 CCMCL1-FOXO1-degron cells, no treatment
- GSM9162766 CCMCL1-FOXO1-degron cells, dTAG47 treated
- GSM9162767 CCMCL1-FOXO1-degron cells, FHD-286 treated
- GSM9162768 UPN1-FOXO1-degron cells, no treatment
- GSM9162769 UPN1-FOXO1-degron cells, dTAG47 treated
- GSM9162770 primary MCL cells (Pt#2)
- GSM9162771 primary MCL cells (Pt#1)
- GSM9162772 primary MCL cells (Pt#3)
- GSM9162773 primary MCL cells (Pt#4)
- GSM9162774 primary MCL cells (Pt#5)
- GSM9162775 primary MCL cells (Pt#6)
- GSM9162776 JEKO1
- GSM9162777 JEKO1-MEF2B HA
- GSM9166463 MINO BRG WT_ATAC
- GSM9166464 MINO BRG T910M_ATAC
- GSM9166465 MINO FHD_ATAC
- GSM9166466 MINO control_ATAC
- GSM9166467 CCMCL1 sgROSA_ATAC
- GSM9166468 CCMCL1 sgBRG1_ATAC
- GSM9166469 CCMCL1 degron no dTAG_ATAC (1)
- GSM9166470 CCMCL1 degron no dTAG_ATAC (2)
- GSM9166471 CCMCL1 degron 2h dTAC_ATAC (1)
- GSM9166472 CCMCL1 degron 2h dTAC_ATAC (2)
- GSM9166473 CCMCL1 degron 8h dTAC_ATAC (1)
- GSM9166474 CCMCL1 degron 8h dTAC_ATAC (2)
- GSM9166475 UPN1 degron no dTAG_ATAC (1)
- GSM9166476 UPN1 degron no dTAG_ATAC (2)
- GSM9166477 UPN1 degron 2h dTAC_ATAC (1)
- GSM9166478 UPN1 degron 2h dTAC_ATAC (2)
- GSM9166479 UPN1 degron 8h dTAC_ATAC (1)
- GSM9166480 UPN1 degron 8h dTAC_ATAC (2)
- GSM9166481 JEKO parent HA
- GSM9166482 JEKO MEF2B HA
- GSM9166483 CM degron no dTAG PAX5
- GSM9166484 CM degron dTAG PAX5
- GSM9166485 CM degron no dTAG HA
+ 23 more — browse all 63 samples with per-sample file links →
- GSE239353 CARD11 gain of function upregulates BCL2A1 and promotes resistance to targeted therapies combination in B-cell lymphoma 18 samples same disease briefing · shares resistance, lymphoma, promotes
- GSE229517 Resistance to PRMT5-targeted therapy in mantle cell lymphoma 6 samples same disease briefing · shares resistance, lymphoma, mantle
- GSE327598 Cyclin-dependent kinase-9 and oxidative phosphorylation inhibition overcome ibrutinib resistance in mantle cell lymphoma 4 samples same disease briefing · shares resistance, lymphoma, mantle
- GSE271664 Functional Genomics and Tumor Microenvironment Analysis Reveal Prognostic Biological Subtypes in Mantle Cell Lymphoma [RNA-seq] 51 samples same disease briefing · shares lymphoma, mantle
- GSE243395 Targeting Lysine Demethylase 5 (KDM5) in Mantle Cell Lymphoma 36 samples same disease briefing · shares lymphoma, mantle
- GSE302906 CUT&RUN profiling of SOX11 and SMARCA4 in mantle cell lymphoma 32 samples same disease briefing · shares lymphoma, mantle
- GSE303064 Gene expression profile at single cell level of primary and relapse mantle cell lymphoma (MCL) 20 samples same disease briefing · shares lymphoma, mantle
- GSE273121 Ironomycin induces Mantle Cell Lymphoma cell death by targeting iron metabolism adicction 12 samples same disease briefing · shares lymphoma, mantle
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.